Showing results (21-30 of 76) with videos related to
Sort By:
Pageof 8
Oncology Reports|January 5, 2006
GnRH agonists and antagonists decrease the metastatic progression of human prostate cancer cell lines by inhibiting the plasminogen activator systemD Dondi, C Festuccia, M Piccolella, et al.European Journal of Neurology|July 2, 2010
Craniocervical dystonia: clinical and pathophysiological featuresC Colosimo, A Suppa, G Fabbrini, et al.Urology|February 1, 1995
Finasteride dose-dependently reduces the proliferation rate of the LnCap human prostatic cancer cell line in vitroM Bologna, P Muzi, L Biordi, et al.Drugs Under Experimental and Clinical Research|January 1, 1985
Norfloxacin concentrations in seminal plasma measured by HPLCM Bologna, L Vaggi, D Flammini, et al.Cancer|May 1, 1989
Bombesin stimulates growth of human prostatic cancer cells in vitroM Bologna, C Festuccia, P Muzi, et al.Current Medicinal Chemistry|June 10, 2011
Cancer multitarget pharmacology in prostate tumors: tyrosine kinase inhibitors and beyondM Bologna, C Vicentini, P Muzi, et al.Drugs Under Experimental and Clinical Research|January 1, 1985
Norfloxacin in prostatitis: correlation between HPLC tissue concentrations and clinical resultsM Bologna, L Vaggi, D Flammini, et al.Anticancer Research|February 24, 2001
Culture conditions modulate cell phenotype and cause selection of subpopulations in PC3 prostate cancer cell lineC Festuccia, G L Gravina, A Angelucci, et al.International Journal of Cancer|February 10, 1998
In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesinC Festuccia, F Guerra, S D'Ascenzo, et al.Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|February 14, 2015
Critical slowing down in networks generating temporal complexityM T Beig, A Svenkeson, M Bologna, et al.Pageof 8